Park Jung-Bin, Jung Kee Wook, Bae June Hwa, Kim Kyuwon, Lee Min Hui, Bae Gyeong-Chae, Hong Seung Wook, Hwang Sung Wook, Park Sang Hyoung, Yang Dong-Hoon, Ye Byong Duk, Byeon Jeong-Sik, Yang Suk-Kyun, Lee Jong Lyul, Yoon Yong Sik, Kim Chan Wook, Yu Chang Sik, Myung Seung-Jae
Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
J Neurogastroenterol Motil. 2025 Oct 30;31(4):501-511. doi: 10.5056/jnm24179.
BACKGROUND/AIMS: Focal hypoganglionosis with adult-onset megacolon (FHAM) is marked by colon dilation proximal to a narrowed segment, with unaffected small bowel motility. Despite similar initial symptoms, FHAM may be more amenable to surgical intervention without recurrence, unlike chronic intestinal pseudo-obstruction (CIPO). The long-term outcomes of FHAM remain underexplored, prompting a comparison of its clinical features and prognosis with CIPO.
We conducted a retrospective analysis of patients presenting with chronic constipation and megacolon, prospectively recruited between January 2017 and December 2023. Within this cohort, 87 patients were diagnosed with FHAM and 13 with CIPO, all of whom were included in the study. The median follow-up period was 3.0 years for patients with FHAM and 2.8 years for those with CIPO.
The proportion of females was greater in both groups (FHAM, 67.8%; CIPO, 53.8%). The median age at diagnosis was similar between the groups (FHAM, 54.5 years; CIPO, 45.3 years). Surgery was performed in 46.0% of patients with FHAM and 69.2% of those with CIPO. Unplanned postoperative hospitalizations and the need for reoperation due to disease recurrence were notably lower in patients with FHAM. None of the patients with FHAM required long-term total parenteral nutrition, in contrast to 46.2% of patients with CIPO. Significant inter-group differences were observed in body mass index at the last follow-up.
Patients with FHAM exhibit a more favorable long-term prognosis and lower postoperative recurrence rates than patients with CIPO. This study underscores the importance of differentiating between these conditions and precisely selecting surgical candidates.
背景/目的:成人起病的巨结肠合并局灶性神经节减少症(FHAM)的特征是狭窄段近端的结肠扩张,小肠蠕动不受影响。尽管初始症状相似,但与慢性假性肠梗阻(CIPO)不同,FHAM可能更适合手术干预且无复发。FHAM的长期预后仍未得到充分研究,促使对其临床特征和预后与CIPO进行比较。
我们对2017年1月至2023年12月前瞻性招募的慢性便秘和巨结肠患者进行了回顾性分析。在该队列中,87例患者被诊断为FHAM,13例被诊断为CIPO,所有患者均纳入研究。FHAM患者的中位随访期为3.0年,CIPO患者为2.8年。
两组女性比例均较高(FHAM组为67.8%;CIPO组为53.8%)。两组诊断时的中位年龄相似(FHAM组为54.5岁;CIPO组为45.3岁)。46.0%的FHAM患者和69.2%的CIPO患者接受了手术。FHAM患者术后非计划性住院和因疾病复发需要再次手术的情况明显较少。与46.2%的CIPO患者相比,FHAM患者均无需长期全胃肠外营养。末次随访时两组患者的体重指数存在显著组间差异。
与CIPO患者相比,FHAM患者表现出更有利的长期预后和更低的术后复发率。本研究强调了区分这些疾病并精确选择手术候选者的重要性。